Darshana Dhote / January 19, 2026 / Inspection Series Blogs
BISmart 2.0: How AI Is Redefining Pharmaceutical Quality Inspection
- Next-Gen AI Architecture: BISmart 2.0 is built on Italy-designed Xsmart architecture with GAMP 5 and 21 CFR Part 11 compliance, replacing traditional rule-based inspection with self-learning AI capable of detecting defects invisible to human inspectors.
- Revolutionary Learning Speed: The system auto-learns from just 12 perfect blister samples, eliminating endless training sessions, manual annotations, and defect library creation while dramatically reducing downtime and time-to-production.
- Advanced Defect Detection: Identifies deshapes, missing fills, embossing flaws, stray hairs, and challenging scenarios like white-on-white and grey-on-grey capsules in clear PVC packaging with consistent accuracy.
- Operational Advantages: Reduces reliance on highly skilled specialists, lowers training requirements for operators, minimizes support loads, and delivers consistent quality standards across all production lines and global facilities.
- Strategic Benefits: Ensures effortless regulatory compliance with validation-ready architecture, provides future-proof scalability for pharmaceutical manufacturing expansion, and eliminates inspection variability for proactive quality assurance.
Pharmaceutical production is no longer just about output; it’s about uncompromising precision and safety.
In a world where one defective blister pack can lead to massive recall and compliance nightmares, BISmart 2.0 emerges as a game-changer.
Built in Italy, powered by next-gen Xsmart architecture, and designed to meet GAMP 5 and 21 CFR Part 11 compliance, BISmart 2.0 is the industry’s smartest blister inspection solution.
Unlike traditional rule-based systems, it’s AI-driven, self-learning, and capable of spotting defects invisible to the human eye.
AI That Learns in Minutes
Forget endless training sessions, manual annotations, and defect library creation.
With BISmart 2.0, operators only need to show 12 perfect blisters — and the system auto-learns.
From there, it identifies deshapes, missing fills, embossing flaws, stray hairs, and even the notoriously challenging “white-on-white” and “grey on grey” capsule setups.
This reduces downtime, lowers skill requirements, and accelerates time-to-production dramatically.
How It Changes the Game for Pharma
- Effortless Compliance: BISmart 2.0 is regulation-ready by default, making validation and audits simpler for pharma companies.
- Future-Proof Manufacturing: With scalability across lines and facilities, pharma leaders can deploy it seamlessly across global sites.
- Smarter Operations, Leaner Costs: Less reliance on highly skilled specialists means lower support loads and faster training for operators.
- Consistent Quality at Scale: By eliminating inspection variability, BISmart 2.0 ensures every blister meets the same rigorous standard — even in complex scenarios such as clear PVC packaging.
BISmart 2.0 – Advancing Pharma Inspection
BISmart 2.0 brings intelligence and precision to pharmaceutical inspection, helping manufacturers achieve higher efficiency, consistency, and compliance.
With its AI-driven capabilities, it enables proactive quality assurance and seamless scalability for the factories of tomorrow.
Conclusion: Where Intelligence Meets Precision, Outsmarting Every Defect
The pharmaceutical sector continues to advance toward smarter, more connected manufacturing, where AI-powered inspection platforms like BISmart 2.0 will set the new benchmark for excellence.
With its unmatched ability to uncover hidden defects, learn in record time, and streamline operations, BISmart 2.0 isn’t just another inspection solution; it represents the future of pharmaceutical quality assurance.
Interested in transforming your pharma inspection process?
Reach us at marketing@jeksonvision.com or call +91 93282 33954 to explore BISmart 2.0.
